Drugs / DV-601
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01023230 | Sep 2009 → May 2011 | chronic hepatitis B virus infection | Dynavax Technologies Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DV-601 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01023230 ↗ |
| Modality | Vaccine | “DV-601, an investigational, therapeutic vaccine” NCT01023230 ↗ |